Close Menu
NEW YORK (GenomeWeb News) – Promega said today that its Maxwell 16 system for DNA-based tests has received the CE Mark, enabling it to be marketed for diagnostic use throughout the European Union.
 
Madison, Wis.-based Promega said that the CE Mark would be particularly helpful for European labs conducting molecular pathology and transplant HLA to be compliant with in vitro diagnostic directives in their countries. The firm noted that the system already meets general purpose medical device requirements in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.